Free Trial

Amdocs Limited $DOX Shares Sold by Robeco Institutional Asset Management B.V.

Amdocs logo with Computer and Technology background

Key Points

  • Robeco Institutional Asset Management B.V. reduced its stake in Amdocs Limited by 0.7%, now holding approximately 0.46% of the company worth $47.56 million as of their latest SEC filing.
  • Amdocs recently announced a quarterly dividend of $0.527, which will be paid on October 31st to shareholders of record as of September 30th, representing an annualized yield of 2.6%.
  • Equities analysts have mixed opinions on Amdocs, with ratings ranging from "buy" to "hold," and a current consensus rating of "Moderate Buy" with an average target price of $108.00.
  • Interested in Amdocs? Here are five stocks we like better.

Robeco Institutional Asset Management B.V. decreased its position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 0.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 521,244 shares of the technology company's stock after selling 3,824 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.46% of Amdocs worth $47,558,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DOX. USA Financial Formulas boosted its holdings in Amdocs by 31.4% in the 2nd quarter. USA Financial Formulas now owns 3,187 shares of the technology company's stock valued at $291,000 after purchasing an additional 761 shares during the last quarter. Trivium Point Advisory LLC lifted its holdings in Amdocs by 11.2% in the second quarter. Trivium Point Advisory LLC now owns 7,285 shares of the technology company's stock valued at $665,000 after acquiring an additional 734 shares during the last quarter. Greenleaf Trust purchased a new position in Amdocs in the second quarter worth approximately $219,000. Dakota Wealth Management acquired a new stake in Amdocs during the second quarter worth $458,000. Finally, Sylvest Advisors LLC raised its position in Amdocs by 14.5% in the second quarter. Sylvest Advisors LLC now owns 4,823 shares of the technology company's stock valued at $440,000 after purchasing an additional 612 shares during the period. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Wolfe Research assumed coverage on Amdocs in a report on Tuesday, July 8th. They set an "outperform" rating for the company. Wall Street Zen lowered shares of Amdocs from a "buy" rating to a "hold" rating in a research note on Friday. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of Amdocs in a research note on Saturday, September 27th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $108.00.

Read Our Latest Analysis on DOX

Amdocs Stock Up 0.3%

Shares of NASDAQ DOX opened at $82.32 on Friday. The stock has a market cap of $9.29 billion, a P/E ratio of 16.70, a PEG ratio of 1.37 and a beta of 0.51. The business's fifty day simple moving average is $85.21 and its 200-day simple moving average is $87.99. Amdocs Limited has a 12-month low of $78.61 and a 12-month high of $95.41. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX - Get Free Report) last released its earnings results on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, topping the consensus estimate of $1.71 by $0.01. The firm had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.13 billion. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.Amdocs's revenue for the quarter was down 8.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.62 EPS. As a group, equities analysts predict that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a $0.527 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.6%. Amdocs's dividend payout ratio is currently 42.80%.

Amdocs Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Recommended Stories

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.